These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 708997)

  • 1. Demonstration of 5-hydroxytryptamine receptors through inhibition by methergoline in cat pial arteries in vitro.
    Edvinsson L; Hardebo JE
    Br J Pharmacol; 1978 Oct; 64(2):281-3. PubMed ID: 708997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Response of isolated segments of hepatic arteries to serotonin in the presence of methergoline].
    Bettini V; Doni MG; Legrenzi E; Santoni G
    Boll Soc Ital Biol Sper; 1979 Aug; 55(16):1572-5. PubMed ID: 553541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of methergoline on serotonin induced contraction of isolated strips of coronary arteries].
    Bettini V; Doni MG; Legrenzi E; Menegazzo P
    Boll Soc Ital Biol Sper; 1979 Jul; 55(13):1271-5. PubMed ID: 508425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man.
    Edvinsson L; Hardebo JE; Owman C
    Circ Res; 1978 Jan; 42(1):143-51. PubMed ID: 618595
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which type of 5-hydroxytryptamine receptor mediates relaxation of the longitudinal muscle of guinea pig proximal colon in vitro?
    Sevcík J; Ruzicka V; Slánsky J; Masek K
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):421-30. PubMed ID: 8900213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE; Sprugel KH; Hadley KB; Roth RA
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
    Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L
    Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleaminergic mechanisms in brain vessels; localization, concentration, uptake and in vitro responses of 5-hydroxytryptamine.
    Edvinsson L; Birath E; Uddman R; Lee TJ; Duverger D; MacKenzie ET; Scatton B
    Acta Physiol Scand; 1984 Jul; 121(3):291-9. PubMed ID: 6206684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of 5-hydroxytryptamine receptors in the rat uterus and stomach strip.
    Wrigglesworth SJ
    Br J Pharmacol; 1983 Dec; 80(4):691-7. PubMed ID: 6571226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical decrease of brain 5-HT turnover by metergoline, a central 5-HT receptor blocker.
    Bourgoin S; Artaud F; Bockaert J; Héry F; Glowinski J; Hamon M
    Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 302(3):313-21. PubMed ID: 662027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation.
    Bond RA; Ornstein AG; Clarke DE
    J Pharmacol Exp Ther; 1989 May; 249(2):401-10. PubMed ID: 2724131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural effects of long term inhibition of 5-hydroxytryptamine receptors using metergoline.
    Stolz JF; Marsden CA
    J Physiol (Paris); 1981; 77(2-3):385-8. PubMed ID: 6974778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries.
    Marin J; Salaices M; Gómez B; Lluch S
    J Pharm Pharmacol; 1981 Nov; 33(11):715-9. PubMed ID: 6118410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the contraction to 5-HT in the canine colon longitudinal muscle.
    Prins NH; Briejer MR; Schuurkes JA
    Br J Pharmacol; 1997 Feb; 120(4):714-20. PubMed ID: 9051313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.
    Apperley E; Humphrey PP; Levy GP
    Br J Pharmacol; 1976 Oct; 58(2):211-21. PubMed ID: 184872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopaminergic agonists and antagonists on isolated cerebral blood vessels.
    Edvinsson L; Hardebo JE; McCulloch J; Owman C
    Acta Physiol Scand; 1978 Nov; 104(3):349-59. PubMed ID: 716985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.